Ketamine derivatives and compositions thereof
US12209060B2 · kind B2 · utility
0Cited by
4References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 1, 2022 |
| Grant date | Jan 28, 2025 |
| Priority date | — |
| Expiry date | Sep 16, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D211/62
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Ketamine derivatives and pharmaceutical compositions thereof are disclosed. When administered orally the ketamine derivatives provide increased bioavailability of ketamine in the systemic circulation. The ketamine derivatives can be used to treat neurological diseases, psychological diseases and pain.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.